Key Takeaways:
– Wellness company, Viome, unveils new toothpaste and gel aimed at improving oral health.
– The MyBiotics Toothpaste and Gel are based on insights from the Oral Health Intelligence test designed by Viome.
– The products help individuals understand the relationship between oral microbes and dental health.
– Viome’s products aim to enhance the mouth’s natural defense mechanisms.
– MyBiotics Gel is aimed at removing plaque and repelling bacteria.
– MyBiotics Toothpaste offers a personalized formula based on an individual’s Oral Health Score.
In an ambitious step towards preventive oral healthcare, Viome, a wellness and diagnostics firm headquartered in Bellevue, Washington, has launched its new products. Viome’s mission is to bring a revolution in oral care by combating the increasing burden of tooth decay and gum diseases affecting a significant portion of U.S adults.
Innovative Oral Health Solution
Viome’s answer to traditional toothpastes, which they claim aren’t efficacious anymore, lies in their innovative MyBiotics Toothpaste and Gel. These products stem from insights garnered from Viome’s Oral Health Intelligence Test. This ground-breaking test is designed to help people understand the correlation between their oral microbiome and the health of their teeth, gums, and breath.
Foundational research shows our oral cavity houses over 700 species of bacteria. These bacteria play a pivotal role in maintaining not only oral health but systemic health as well. Our oral microbiome connects directly with our overall health and wellness, establishing the need to keep it balanced.
A Look into Viome
Established eight years ago by serial entrepreneur Naveen Jain, Viome began with an aim to explore the labyrinth of gut microbiome and its implications on health. The company offers kits for home use that analyze the microbes in stool samples and suggest food recommendations accordingly. They also provide supplements and probiotics to cater to the requirements of the gut.
Over the past few years, Viome has expanded its focus to comprehend the oral microbiome. Their objective is to develop products that naturally enhance the defense mechanisms of the mouth.
The MyBiotics Range
Viome offers a deep morning clean with its MyBiotics Gel, aimed at eliminating plaque and warding off bacteria. Formulated based on 26 independent research studies from leading U.S universities, the gel exemplifies Viome’s commitment to research-based solutions.
On the other hand, the MyBiotics Toothpaste provides an oral supplement integrated with a user’s unique formula. It contains prebiotics, postbiotics, and other ingredients drawn from the user’s Oral Health Score. Both the toothpaste and the gel come at a monthly cost of $79, including an oral health test, with a commitment for a minimum of three months.
The Power behind Viome
Viome employs a combination of proprietary RNA sequencing methods and artificial intelligence to power their insights. With investments hitting $175 million, including an $86.5 million Series C round in August, Viome is undoubtedly a force to be reckoned within the world of digital health. It has even struck a deal with CVS to vend its gut microbiome test in 200 CVS stores across the U.S.
Viome operates mainly in the Seattle region, with its corporate office in Bellevue and a lab in Bothell. As it steps into oral health, it is set to face competition from startups taking a swing at oral hygiene giants with their toothpastes and oral care products. Yet, with its research-backed products and AI-powered insights, Viome may change the oral health landscape for the better.
